Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To report the efficacy of intravitreal injection of ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP) in neovascular age-related macular degeneration (AMD).
Case review of four consecutive patients who received 3 injections at monthly intervals of intravitreal ranibizumab injections for RAP. The serial changes in best-corrected visual acuity (BCVA), optical coherence tomography (OCT), fluorescein angiography (FA), and indocyanine green angiography (ICGA) are presented.
The baseline mean logMAR BCVA was 0.89 (Snellen equivalent of 20/155). After three injections of ranibizumab, all four patients had visual improvement and the mean logMAR BCVA improved to 0.59 (Snellen equivalent of 20/78). The mean visual improvement was 3.0 lines. All patients also had complete resolution of subretinal fluid after treatment, and the mean OCT central foveal thickness reduced from 438 μm at baseline to 169 μm at 3 months. Follow-up FA and ICGA at 3 months showed absence of leakage in three patients with minimal leakage in the remaining patient. One patient had recurrence of RAP at 8 months after commencement of treatment, and repeat ranibizumab injection resulted in resolution of the subretinal fluid and pigment epithelial detachment and visual improvement.
Intravitreal ranibizumab injections appeared to be an effective treatment for RAP, resulting in visual gain and reduction in macular thickness. Further long-term studies to evaluate the efficacy of intravitreal ranibizumab in RAP are warranted.
- Bottoni, F, Massacesi, A, Cigada, M, Viola, F, Musicco, I, Staurenghi, G (2005) Treatment of retinal angiomatous proliferation in age-related macular degeneration. Arch Ophthalmol 123: pp. 1644-1650 CrossRef
- Bottoni, F, Romano, M, Massacesi, A, Bergamini, F (2006) Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244: pp. 1528-1533 CrossRef
- Brown, DM, Kaiser, PK, Michels, M, Soubrane, G, Heier, JS, Kim, RY, Sy, JP, Schneider, S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: pp. 1432-1444 CrossRef
- Donati, MA, Carifi, G, Virgili, G, Menchini, U (2006) Retinal angiomatous proliferation: association with clinical and angiographic features. Ophthalmologica 220: pp. 31-36 CrossRef
- Fung, AE, Lalwani, GA, Rosenfeld, PJ, Dubovy, SR, Michels, S, Feuer, WJ, Puliafito, CA, Davis, JL, Flynn, HW, Esquiabro, M (2007) An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143: pp. 566-583 CrossRef
- Freund, KB, Klais, CM, Eandi, CM, Ober, MD, Goldberg, DE, Sorenson, JA, Yannuzzi, LA (2006) Sequenced combined intraivtreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124: pp. 487-492 CrossRef
- Joeres S, Heussen MA, Treziak T, Bopp S, Joussen AM (2007) Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol DOI 10.1007/s00417-007-0580-y
- Meyerle, CB, Freund, KB, Iturralde, D, Spaide, RF, Sorenson, JA, Slakter, JS, Klancnik, JM, Fisher, YL, Cooney, MJ, Yannuzzi, LA (2007) Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27: pp. 451-457 CrossRef
- Rosenfeld, PJ, Brown, DM, Heier, JS, Boyer, DS, Kaiser, PK, Chung, CY, Kim, RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: pp. 1419-1431 CrossRef
- Yannuzzi, LA, Negrao, S, Iida, T, Carvalho, C, Rodriguez-Coleman, H, Slakter, J, Fruend, KB, Sorenson, J, Orlock, D, Borodoker, N (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21: pp. 416-434 CrossRef
- Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology
Volume 245, Issue 12 , pp 1877-1880
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Retinal angiomatous proliferation
- Age-related macular degeneration
- Industry Sectors